Low-dose Recombinant Leukocyte Interferon-alpha Treatment of Hepatitis C Viral Infection in Renal Transplant Recipients. A Pilot Study
Overview
Affiliations
Management of patients with hepatitis C infection and renal disease.
Bunchorntavakul C, Maneerattanaporn M, Chavalitdhamrong D World J Hepatol. 2015; 7(2):213-25.
PMID: 25729476 PMC: 4342603. DOI: 10.4254/wjh.v7.i2.213.
Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho R, Feldner A, Silva A, Ferraz M World J Gastroenterol. 2015; 21(2):408-22.
PMID: 25593456 PMC: 4292272. DOI: 10.3748/wjg.v21.i2.408.
Kim J, Park H, Jang H, Park J, Kwon C, Huh W Ann Surg Treat Res. 2014; 86(5):256-63.
PMID: 24851227 PMC: 4024934. DOI: 10.4174/astr.2014.86.5.256.
Treatment of HCV patients before and after renal transplantation.
Du L, Tang H Hepat Mon. 2012; 11(11):880-6.
PMID: 22308151 PMC: 3269055. DOI: 10.5812/kowsar.1735143X.712.
Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.
Aljumah A, Saeed M, Al Flaiw A, Al Traif I, Al Alwan A, Al Qurashi S World J Gastroenterol. 2012; 18(1):55-63.
PMID: 22228971 PMC: 3251806. DOI: 10.3748/wjg.v18.i1.55.